Effect of different immunosuppressive drugs on immune cells from young and old healthy persons

Gerontology

Volumn 60, Issue 3, 2014, Pages 229-238

  Welzl, Kathrin ^a,b   Kern, Georg ^b   Mayer, Gert ^b   Weinberger, Birgit ^a   Säemann, Marcus D ^c   Sturm, Gisela ^b   Grubeck Loebenstein, Beatrix ^a   Koppelstaetter, Christian ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aging; Immunosuppressive drugs; Peripheral mononuclear cells

Indexed keywords

CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 2; PHYTOHEMAGGLUTININ; RAPAMYCIN; TACROLIMUS; HYDROGEN PEROXIDE; CALCINEURIN INHIBITOR; CYCLOSPORIN; IL2 PROTEIN, HUMAN; IMMUNOSUPPRESSIVE AGENT; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ADULT; AGE; AGED; ARTICLE; BLOOD; CD3+ T LYMPHOCYTE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TELOMERE; TELOMERE SHORTENING; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; NORMAL HUMAN; YOUNG ADULT; AGING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; CALCINEURIN INHIBITORS; CELL PROLIFERATION; CYCLOSPORINE; FEMALE; HUMANS; HYDROGEN PEROXIDE; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MALE; PHYTOHEMAGGLUTININS; SIROLIMUS; TACROLIMUS; TELOMERE SHORTENING; TOR SERINE-THREONINE KINASES; YOUNG ADULT;

EID: 84899440403     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000356020     Document Type: Article

References (44)

1. Cohen DJ, St Martin L, Christensen LL, Bloom RD, Sung RS: Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant 2006; 6: 1153-1169.
2. Danovitch GM, Cohen DJ, Weir MR, Stock PG, Bennett WM, Christensen LL, Sung RS: Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant 2005; 5: 904-915.
3. Singhal A, Sezginsoy B, Ghuloom AE, Hutchinson IV, Cho YW, Jabbour N: Orthotopic liver transplant using allografts from geriatric population in the United States: is there any age limit Exp Clin Transplant 2010; 8: 196-201.
4. Weiss ES, Nwakanma LU, Patel ND, Yuh DD: Outcomes in patients older than years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database. J Heart Lung Transplant 2008; 27: 184-191.
5. Oniscu GC, Brown H, Forsythe JL: Impact of cadaveric renal transplantation on survival in patients listed for transplantation. J Am Soc Nephrol 2005; 16: 1859-1865.
6. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. New Engl J Med 1999; 341: 1725-1730.
7. Meier-Kriesche HU, Port FK, Ojo AO, Rudich SM, Hanson JA, Cibrik DM, Leichtman AB, Kaplan B: Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58: 1311-1317.
8. Gill JS, Tonelli M, Johnson N, Kiberd B, Landsberg D, Pereira BJ: The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. Kidney Int 2005; 68: 2345-2351.
9. Frei U, Noeldeke J, Machold-Fabrizii V, Arbogast H, Margreiter R, Fricke L, Voiculescu A, Kliem V, Ebel H, Albert U, Lopau K, Schnuelle P, Nonnast-Daniel B, Pietruck F, Offermann R, Persijn G, Bernasconi C: Prospective age-matching in elderly kidney transplant recipients-a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8: 50-57.
10. Weinberger B, Grubeck-Loebenstein B: Vaccines for the elderly. Clin Microbiol Infect 2012; 18(suppl 5):100-108.
11. Weinberger B, Weiskopf D, Grubeck-Loebenstein B: Immunology and aging; in Hazzards Geriatric Medicine and Gerontology. New York, McGraw-Hill, 2009.
12. Arnold CR, Wolf J, Brunner S, Herndler-Brandstetter D, Grubeck-Loebenstein B: Gain and loss of T cell subsets in old age-age-related reshaping of the T cell repertoire. J Clin Immunol 2011; 31: 137-146.
13. Cicin-Sain L, Smyk-Pearson S, Currier N, Byrd L, Koudelka C, Robinson T, Swarbrick G, Tackitt S, Legasse A, Fischer M, Nikolich-Zugich D, Park B, Hobbs T, Doane CJ, Mori M, Axthelm MK, Lewinsohn DA, Nikolich-Zugich J: Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates. J Immunol 2010; 184: 6739-6745.
14. Naylor K, Li G, Vallejo AN, Lee WW, Koetz K, Bryl E, Witkowski J, Fulbright J, Weyand CM, Goronzy JJ: The influence of age on T cell generation and TCR diversity. J Immunol 2005; 174: 7446-7452.
15. Yager EJ, Ahmed M, Lanzer K, Randall TD, Woodland DL, Blackman MA: Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med 2008; 205: 711-723.
16. Almanzar G, Schwaiger S, Jenewein B, Keller M, Herndler-Brandstetter D, Wurzner R, Schonitzer D, Grubeck-Loebenstein B: Longterm cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 2005; 79: 3675-3683.
17. Brunner S, Herndler-Brandstetter D, Weinberger B, Grubeck-Loebenstein B: Persistent viral infections and immune aging. Ageing Res Rev 2011; 10: 362-369.
18. Pawelec G, Koch S, Gouttefangeas C, Wikby A: Immunorejuvenation in the elderly. Rejuvenation Res 2006; 9: 111-116.
19. Danovitch GM, Gill J, Bunnapradist S: Immunosuppression of the elderly kidney transplant recipient. Transplantation 2007; 84: 285-291.
20. Miura M, Satoh S, Kagaya H, Saito M, Inoue T, Tsuchiya N, Suzuki T, Habuchi T: No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone month after renal transplantation. Eur J Clin Pharmacol 2009; 65: 1047-1053.
21. Staatz CE, Tett SE: Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs Aging 2005; 22: 541-557.
22. Wang CX, Meng FH, Chen LZ, Ren B, Li SX, Fei JG, Qiu J, Deng SX, Li J, Chen SY: Population pharmacokinetics of mycophenolic acid in senile Chinese kidney transplant recipients. Transplant Proc 2007; 39: 1392-1395.
23. Waki K: UNOS Liver Registry: ten year survivals. Clin Transpl 2006: 29-39.
24. Gill J, Sampaio M, Gill JS, Dong J, Kuo HT, Danovitch GM, Bunnapradist S: Induction immunosuppressive therapy in the elderly kidney transplant recipient in the United States. Clin J Am Soc Nephrol 2011; 6: 1168-1178.
25. Meier-Kriesche HU, Li S, Gruessner RW, Fung JJ, Bustami RT, Barr ML, Leichtman AB: Immunosuppression: evolution in practice and trends, 1994-2004. Am J Transplant 2006; 6: 1111-1131.
26. Veroux M, Tallarita T, Corona D, Sinagra N, Giaquinta A, Zerbo D, Guerrieri C, DAssoro A, Cimino S, Veroux P: Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation. Clin Dev Immunol 2013; 2013: 496974.
27. Jennings P, Koppelstaetter C, Aydin S, Abberger T, Wolf AM, Mayer G, Pfaller W: Cyclosporine A induces senescence in renal tubular epithelial cells. Am J Physiol Renal Physiol 2007; 293:F831-F838.
28. Halloran PF: Immunosuppressive drugs for kidney transplantation. New Engl J Med 2004; 351: 2715-2729.
29. Schiffer M: Renal co-morbidity after solid organ transplantation. Dtsch Med Wochenschr 2012; 137: 2332-2335.
30. Pascher A, Pratschke J, Neuhaus P, Tullius SG: Modifications of immune regulations with increasing donor and recipient age. Ann Transplant 2004; 9: 72-73.
31. Pascual J, Marcen R, Ortuno J: Clinical experience with everolimus (Certican) in elderly recipients: the old-for-old concept. Transplantation 2005; 79:S85-S88.
32. Ponticelli C: Present and future of immunosuppressive therapy in kidney transplantation. Transplant Proc 2011; 43: 2439-2440.
33. Halloran PF: Immunosuppression in the post-adaptation period. Transplantation 2000; 70: 3-5.
34. Kahan BD: Sirolimus: a comprehensive review. Expert Opin Pharmacother 2001; 2: 1903-1917.
35. Lebranchu Y: Can we eliminate both calcineurin inhibitors and steroids Transplant Proc 2010; 42:S25-S28.
36. Babizhayev MA, Yegorov YE: Smoking and health: association between telomere length and factors impacting on human disease, quality of life and life span in a large population-based cohort under the effect of smoking duration. Fundam Clin Pharmacol 2011; 25: 425-442.
37. Batty GD, Wang Y, Brouilette SW, Shiels P, Packard C, Moore J, Samani NJ, Ford I: Socioeconomic status and telomere length: the West of Scotland Coronary Prevention Study. J Epidemiol Community Health 2009; 63: 839-841.
38. Richter T, Proctor C: The role of intracellular peroxide levels on the development and maintenance of telomere-dependent senescence. Exp Gerontol 2007; 42: 1043-1052.
39. Kurz DJ, Decary S, Hong Y, Trivier E, Akhmedov A, Erusalimsky JD: Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci 2004; 117: 2417-2426.
40. Scalera F, Borlak J, Beckmann B, Martens-Lobenhoffer J, Thum T, Tager M, Bode-Boger SM: Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl L-arginine accelerates endothelial cell senescence. Arterioscler Thromb Vasc Biol 2004; 24: 1816-1822.
41. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ: Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007; 369: 107-114.
42. Benetos A, Gardner JP, Zureik M, Labat C, Xiaobin L, Adamopoulos C, Temmar M, Bean KE, Thomas F, Aviv A: Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension 2004; 43: 182-185.
43. Cawthon RM, Smith KR, OBrien E, Sivatchenko A, Kerber RA: Association between telomere length in blood and mortality in people aged years or older. Lancet 2003; 361: 393-395.
44. Araki K, Turner AP, Shaffer VO, Gangappa S, Keller SA, Bachmann MF, Larsen CP, Ahmed R: mTOR regulates memory CD8 T-cell differentiation. Nature 2009; 460: 108-112